258 related articles for article (PubMed ID: 30097339)
1. Comparative effectiveness of add-on therapy with newer-generation antiepileptic drugs in Bulgarian patients with refractory epilepsy.
Viteva E; Zahariev Z
Epilepsy Behav; 2018 Oct; 87():137-145. PubMed ID: 30097339
[TBL] [Abstract][Full Text] [Related]
2. Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.
Socała K; Wyska E; Szafarz M; Nieoczym D; Wlaź P
Neuropharmacology; 2019 Nov; 158():107733. PubMed ID: 31377197
[TBL] [Abstract][Full Text] [Related]
3. Topiramate Effectiveness as Add-on Therapy in Bulgarian Patients with Drug-resistant Epilepsy.
Viteva E; Zahariev Z
Folia Med (Plovdiv); 2020 Dec; 62(4):712-722. PubMed ID: 33415915
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam effectiveness as add-on therapy in Bulgarian patients with drug-resistant epilepsy.
Viteva EI; Zahariev ZI
Folia Med (Plovdiv); 2021 Apr; 63(2):234-241. PubMed ID: 33932014
[TBL] [Abstract][Full Text] [Related]
6. Various Aspects of Tiagabine Effectiveness as Add-on Therapy in Patients with Refractory Epilepsy.
Viteva E; Zahariev Z
Folia Med (Plovdiv); 2020 Mar; 62(1):59-64. PubMed ID: 32337898
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.
Otoul C; Arrigo C; van Rijckevorsel K; French JA
Clin Neuropharmacol; 2005; 28(2):72-8. PubMed ID: 15795549
[TBL] [Abstract][Full Text] [Related]
8. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Patsalos PN; Sander JW
Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market.
Mäkinen J; Peltola J; Raitanen J; Alapirtti T; Rainesalo S
J Neurol; 2017 Jul; 264(7):1345-1353. PubMed ID: 28567538
[TBL] [Abstract][Full Text] [Related]
10. [Newer antiepileptic drugs].
Matsuura M
No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis.
Zhuo C; Jiang R; Li G; Shao M; Chen C; Chen G; Tian H; Li J; Xue R; Jiang D
Sci Rep; 2017 May; 7(1):2535. PubMed ID: 28566726
[TBL] [Abstract][Full Text] [Related]
12. [Antiepileptic drugs in North America].
Akiyama T; Otsubo H
Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
[TBL] [Abstract][Full Text] [Related]
13. Use of second-generation antiepileptic drugs in the pediatric population.
Chung AM; Eiland LS
Paediatr Drugs; 2008; 10(4):217-54. PubMed ID: 18590343
[TBL] [Abstract][Full Text] [Related]
14. [Newer antiepileptic drugs].
Matsuura M
Brain Nerve; 2007 Feb; 59(2):147-56. PubMed ID: 17380779
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of new antiepileptic drugs: a network meta-analysis.
Zaccara G; Giovannelli F; Giorgi FS; Franco V; Gasparini S; Benedetto U
Eur J Clin Pharmacol; 2017 Jul; 73(7):811-817. PubMed ID: 28378057
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study.
Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C
Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J
Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458
[TBL] [Abstract][Full Text] [Related]
20. Dronedarone (a multichannel blocker) enhances the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
Sawicka KM; Florek-Łuszczki M; Wawryniuk A; Daniluk J; Wróblewska-Łuczka P; Chmielewski J; Karwan S; Łuszczki JJ
Epilepsy Res; 2019 Aug; 154():62-68. PubMed ID: 31059963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
